AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$1M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 0 added, 1 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- Open
- $26.12
- 52-wk high
- $40.22
- High
- $26.69
- 52-wk low
- $20.32
- Low
- $25.88
- Prev close
- $25.88
- Mkt cap
- $1.67B
- Volume
- 1.00M
- Fwd P/E
- 204.1x
- Beta
- 1.23
- P/S
- 60.5x
- P/B
- 4.9x
- Profit margin
- +0.0%
- Op margin
- -702.0%
- ROE
- -61.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about STOK filings
Are insiders buying or selling Stoke Therapeutics Inc (STOK) stock?
Net selling: insiders sold $1M and bought $0 of STOK stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. $378K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Ticho, Barry (Chief Medical Officer), who sold $531K. The latest filing was on Sep 3, 2026.
Which members of Congress have traded STOK recently?
None. No member of Congress disclosed a STOK trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this STOK smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- BO
Bank of America
$11.1M
added
Sells/Trims (2)
- P7
Point72
$38.8M
sold
- BO
Bank of America
$9.2M
trimmed
What insiders are doing
How top traders are positioned
No tracked top-trader positions in STOK right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 13.4% below what analysts expected.
Earnings per share
-$0.82 expected
Reports Nov 3, 2026, in 33 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $10.6M | $1.4M | $6.2M | $9.3M |
| Cost of what it sold | $989.0K | $1.1M | $1.0M | $1.1M |
| Gross profit | $9.6M | $347.0K | $5.2M | $8.2M |
| What it spent | ||||
| Research and development | $37.3M | $41.3M | $39.7M | $49.0M |
| Sales and admin | $16.0M | $21.1M | $20.0M | $25.3M |
| Other operating costs | -$547.0K | -$650.0K | -$1.0M | — |
| Total operating expenses | $52.7M | $61.8M | $58.6M | $73.6M |
| What was left | ||||
| Operating profit | -$43.1M | -$61.4M | -$53.4M | -$65.4M |
| Interest on debt | $3.0K | $3.0K | $23.0K | $17.0K |
| Profit before tax | -$39.6M | -$57.9M | -$50.0M | -$61.6M |
| Tax | -$1.3M | — | — | — |
| Net profit | -$38.3M | -$57.9M | -$50.0M | -$61.6M |
| EBITDA | -$38.6M | -$56.9M | -$45.6M | -$64.3M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace